DHR
64
-4
WMT
60
-2
TSN
55
-5
HCA
60
-4
NWL
58
-2
CF
42
-6
LLY
68
-2
LH
48
-2
FCX
72
-2
MCO
64
2
ORLY
40
-4
MCHP
45
-4
TGNA
58
2
NUE
57
4
ADP
62
-3
NWS
52
4
APA
48
-5
BXP
42
-4
BDX
60
-4
MET
64
-2
DHR
64
-4
WMT
60
-2
TSN
55
-5
HCA
60
-4
NWL
58
-2
CF
42
-6
LLY
68
-2
LH
48
-2
FCX
72
-2
MCO
64
2
ORLY
40
-4
MCHP
45
-4
TGNA
58
2
NUE
57
4
ADP
62
-3
NWS
52
4
APA
48
-5
BXP
42
-4
BDX
60
-4
MET
64
-2
Financhill
Back

NBI Canadian Dividend Income ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
49

NDIV.TO
NBI Canadian Dividend Income ETF

Last Price:
$38.65
Seasonality Move:
0.37%
Buy
64

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$88.61
Seasonality Move:
-30.03%
Sell
49
NBI Canadian Dividend Income ETF (NDIV.TO) is a Sell

Is NBI Canadian Dividend Income ETF a Buy, Sell or Hold?

  • The current NBI Canadian Dividend Income ETF [NDIV.TO] share price is $38.54. The Score for NDIV.TO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NDIV.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $93.99. The Score for DRUG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NDIV.TO Stock Price Chart

What is NBI Canadian Dividend Income ETF's stock price today?

  • The NBI Canadian Dividend Income ETF share price today is $38.54
    The current trend is moderately bullish and NDIV.TO is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $93.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

NDIV.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 55.59 Buy
Chaikin Money Flow: -38496 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.77 - 38.63) Buy
Bollinger Bands (100): (36.82 - 38.36) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.78 Buy
Relative Strength Index (14 RSI): 76.13 Buy
Chaikin Money Flow: 147064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.66 - 81.44) Buy
Bollinger Bands (100): (40.97 - 68.09) Buy

NDIV.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.6 Sell
20-day SMA: 38.3 Buy
50-day SMA: 37.97 Buy
200-day SMA: 36.05 Buy
8-day EMA: 38.61 Sell
20-day EMA: 38.36 Buy
50-day EMA: 37.28 Buy
200-day EMA: 23.45 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.53 Buy
20-day SMA: 72.88 Buy
50-day SMA: 64.83 Buy
200-day SMA: 42.54 Buy
8-day EMA: 84.37 Buy
20-day EMA: 75.93 Buy
50-day EMA: 66.06 Buy
200-day EMA: 46.89 Buy

NBI Canadian Dividend Income ETF Earnings Growth & NDIV.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

NBI Canadian Dividend Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):